Clinical Certificate

Anxiety Disorders

Date: Thursday 24th January 2019 – Friday 25th January 2019
Venue: The Bristol Hotel, Prince Street, Bristol, BS1 4QF
Accommodation: The Bristol Hotel, Prince Street, Bristol, BS1 4QF
(accommodation is bookable separately when you complete the online booking form)
Organised by: David Nutt and John Potokar
Booking Status: FULLY BOOKED. Please email to be placed on the waiting list.

Programme

Thursday 24 January
13:00–13:30 Arrival, registration and light lunch
13:30–13:35 Introduction
Dr John Potokar (Bristol)
13:35–15:00 Evidence-based pharmacological treatment of anxiety disorders
Professor David Baldwin (Southampton)
15:00–15:15 Refreshments
15:15–16:30 Two Groups
Group A: Anxiety in the Medical Setting
Dr John Potokar (Bristol) and Dr Nicola Taylor (Bristol)
Group B: Benzodiazepines in Anxiety Disorders
Dr Fergus Law (Bristol) and Dr Jan Melichar (Bristol)
16:30–16:45 Refreshments and presenters swap rooms
16:45–18:00 Two Groups (repeated)
Group A: Anxiety in the Medical Setting
Dr John Potokar and Dr Nicola Taylor
Group B: Benzodiazepines in Anxiety Disorders
Dr Fergus Law and Dr Jan Melichar
18:00 End of Thursday Sessions
Friday 25 January
08:45–09:15 Arrival and Coffee
09:15–10:45 The fast and the slow: exploring the duality of anxiolytic action
Professor David Nutt (London)
10:45–11:00 Refreshments
11:00–12:30 Practical therapy of anxiety: case studies
Professor David Nutt and Dr David Christmas (Cambridge)
12:30–13:15 Lunch
13:15–14:30 Two Groups
Group A: Exploring Brain Mechanisms in SSRI Action
Professor David Nutt and Dr David Christmas
Group B: Insomnia and other Sleep Disturbances
Dr Hugh Selsick (London) and Dr David O'Regan (London)
14:30–14:45 Refreshments and presenters swap rooms
14:45–16:00 Two Groups (repeated)
Group A: Exploring Brain Mechanisms in SSRI Action
Professor David Nutt and Dr David Christmas
Group B: Insomnia and other Sleep Disturbances
Dr Hugh Selsick and Dr David O'Regan
16:00 End of meeting, return of feedback forms

Last edited 24th February 2020

Learning Objectives

At the end of one and a half day course, delegates will:

  • Be aware of current theories and the causes and neurochemistry of anxiety.
  • Know the pharmacology of both GABA and 5-HT acting anxiolytic drugs.
  • Have an understanding of the current clinical assessment of the various anxiety disorders.
  • Be aware of the merits and demerits of the various different classes of anxiolytic agents.
  • Understand the ongoing methodologies for investigating brain mechanisms of anxiety.
  • Know the clinical and pharmacology background of underpinning rational use of hypnotics.
  • Have an insight into the way alcohol acts on the brain and how these effects can be minimised.

This module is eligble for 10 CPD hours which are subject to peer group review.

Feedback from 2020 Module

"This was so well organised - thank you! And the content is highly relevant and pitched at a good level. The catering was also excellent!"

"Very unusual to have such fantastic, consistent excellence. Thank you!"

"Excellent content and engagement throughout – an always with BAP events!"

Print DOIs